Mitral Regurgitation: Echocardiographic Assessment

Mitral regurgitation (MR) is backward flow of blood from the left ventricle into the left atrium during systole. It may present acutely or chronically, and — critically — it may arise from a structural problem with the valve itself (primary MR) or from a normal valve rendered incompetent by disease of the left ventricle or atrium (secondary, or functional, MR). This distinction matters enormously: it changes both the severity thresholds used and the management approach, and this tutorial covers both, with criteria drawn from the 2020 ACC/AHA and 2025 ESC/EACTS valvular heart disease guidelines.

Etiology

MR can arise from an abnormality in any component of the mitral valve apparatus:

• Mitral annulus — dilation, calcification
• Mitral leaflets — prolapse, endocarditis, flail leaflet, rheumatic heart disease, restriction from fibrotic endocardial disease (as in endomyocardial fibrosis, where posterior leaflet motion is mechanically tethered rather than structurally diseased)
• Chordae tendineae — elongation, rupture
• Papillary muscles — fibrosis, calcification, ischemia, rupture
• Ventricular myocardium — ischemia, infarction

Leaflet, annular, and chordal causes are generally classified as primary MR — the pathology is intrinsic to the valve. Papillary muscle and myocardial causes acting through LV dilation, dysfunction, or dyssynchrony — without a primary structural leaflet abnormality — are classified as secondary (functional) MR, sometimes further split into ventricular (from LV remodeling, as in dilated cardiomyopathy, or acutely in myocarditis) and atrial (from LA dilation, often with atrial fibrillation) subtypes. A third, mechanistically distinct category is worth naming explicitly: MR from systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy, where leaflet coaptation is disrupted by the leaflet itself being pulled toward the septum rather than by annular dilation or papillary displacement.

M-Mode Findings

• Left atrial enlargement
• Left ventricular enlargement, secondary to chronic volume overload
• An LV volume overload pattern: hyperkinetic LV walls with dilation
• Indirect evidence of pulmonary hypertension, such as increased estimated pulmonary artery pressure

2D Echocardiographic Findings

• Identification of the anatomic basis for MR — mitral annular calcification, leaflet prolapse or flail, or regional/global wall motion abnormality suggesting a secondary etiology
• Left atrial and ventricular enlargement, reflecting the chronic volume overload pattern
• Rapid, sideways systolic expansion of the left atrium
• An increased left atrial–to–right atrial (LA/RA) size ratio (normal is roughly 1:1) — a useful dynamic clue to significant MR
• Abnormal systolic bowing of the interatrial septum
• Evidence of pulmonary hypertension

Doppler Assessment

Pulsed-Wave Doppler

• An elevated peak mitral E velocity (> 1.3 m/s) is a supportive sign of significant regurgitation, reflecting the increased diastolic transmitral flow volume — not a primary grading parameter on its own
• Regurgitant jet mapping and regurgitant fraction both help characterize severity (see below)
• Abnormal LV diastolic filling patterns — a pseudonormal (Stage II) or restrictive (Stage III) pattern — are associated with severe MR and elevated left atrial pressure
• Pulmonary venous inflow: a diminished or reversed systolic (S) wave with an increased diastolic (D) wave is a supportive sign of significant MR, reflecting elevated LA pressure transmitted back into the pulmonary veins

Continuous-Wave Doppler

• A dense, complete regurgitant spectral envelope supports significant MR
• An asymmetrical velocity envelope — a rapid early systolic rise — suggests a rapid rise in left atrial pressure from significant regurgitation
• A shortened isovolumic relaxation time (< 60 ms) is a further supportive sign of severe MR with elevated LA pressure
• The regurgitant jet velocity itself is a poor severity marker in isolation — even a small, hemodynamically insignificant jet can reach high velocity, since it simply reflects the LV-to-LA pressure gradient. A jet with a velocity that appears unexpectedly low can indicate very elevated left atrial pressure equalizing with the LV, which is itself a marker of severity — interpret this finding in the context of the whole study, not alone

Color Flow Doppler

• Jet area and the jet area-to-left atrial area ratio are qualitative/semi-quantitative severity clues, but are heavily dependent on technical and hemodynamic factors (driving pressure, jet direction, machine gain) and are less favored today than direct quantitative parameters. A ratio >40% is one of the supportive criteria for severe MR in the current ACC/AHA staging table, but should not be used in isolation.
• Vena contracta width — the narrowest width of the jet at the valve orifice — is a core semi-quantitative parameter (see grading below)
• Proximal acceleration (flow convergence), visualized as PISA, indicates at least moderate-to-severe MR and forms the basis for quantitative calculation of the effective regurgitant orifice area (EROA)

Guideline-Based Severity Grading

This is the most important distinction to understand: primary and secondary MR use different guideline thresholds, and the current guideline “severe” cutoffs for primary MR sit meaningfully higher than the regurgitant fraction some classic teaching schemes call “severe.”

Primary MR (ACC/AHA 2020 Table 17)

Stage	Vena contracta	Regurgitant volume	Regurgitant fraction	EROA
Progressive (mild–moderate)	< 0.7 cm	< 60 mL/beat	< 50%	< 0.40 cm²
Severe	≥ 0.7 cm	≥ 60 mL/beat	≥ 50%	≥ 0.40 cm²

A central color jet occupying >40% of the left atrial area, or a holosystolic eccentric jet, is a further supportive (but not standalone) criterion for severe primary MR in the same table.

Secondary MR (ACC/AHA 2020 Table 18; refined by ESC 2025)

The ACC/AHA 2020 table lists the same numeric cutoffs for secondary MR as for primary MR (EROA ≥0.40 cm², regurgitant volume ≥60 mL/beat), while explicitly noting that PISA-based EROA tends to underestimate the true orifice in secondary MR because of its crescentic, elliptical shape — meaning the true severity is often greater than the raw number suggests.

The 2025 ESC/EACTS guideline goes further, stating that lower thresholds may apply to define severe secondary MR: an EROA ≥0.30 cm² (≥30 mm²) and/or a regurgitant volume ≥45 mL has been identified as having a significant impact on outcomes, with this lower bar reflecting the elliptical orifice shape and the frequent low-flow state in secondary MR patients — and is consistent with the patient-selection criteria used in trials such as COAPT, which established the benefit of transcatheter edge-to-edge repair in appropriately selected secondary MR.

Classic (Descriptive) Grading Scheme

A four-tier grading scheme (1+ to 4+), integrating clinical, 2D, and Doppler findings, remains common in descriptive echo reporting:

Grade	Regurgitant fraction	Summary
1+ (Mild)	< 20%	Normal chamber sizes; normal history, exam, ECG, and chest X-ray
2+ (Moderate)	20–30%	Mild LA/LV enlargement; complete CW envelope
3+ (Moderately severe)	30–40%	Moderate–severe LA/LV enlargement; wide color jet; visible flow convergence
4+ (Severe)	> 40%	LA/LV enlargement; complete lack of systolic leaflet coaptation; jet area/LA area >40%

This is the key discrepancy to flag: the classic scheme’s “severe” (4+) tier starts at a regurgitant fraction of just over 40%, while the current ACC/AHA staging table requires RF ≥50% for the same “severe” designation. An RF in the 40–49% range would be classified as Stage B (progressive, not yet severe) by the current guideline table, even though older grading conventions would already call it 4+/severe. As with mitral stenosis, this isn’t a case of one scheme being wrong — the classic scheme grades a continuum, while the guideline table sets the specific threshold intervention decisions are built around. Favor the guideline table for management-relevant reporting.

A note on sourcing: some references list an aortic-to-mitral velocity or flow ratio as a supportive parameter in MR assessment; this wasn’t found as a defined MR-severity criterion in either guideline reviewed for this page, so it hasn’t been included above pending a clearer source.

Practical Pearls

• Always determine primary versus secondary etiology early — it changes both the applicable severity thresholds and the entire management pathway.
• Use an integrative approach combining 2D/color findings with quantitative parameters; don’t grade severity from jet area or velocity alone.
• Be cautious grading MR in the immediate post-intervention period (after surgical repair or transcatheter edge-to-edge repair) — hemodynamics haven’t equilibrated, and standard thresholds may not apply reliably.
• In secondary MR, remember the lower EROA/regurgitant volume thresholds for severity — using the primary-MR cutoffs can under-call a genuinely severe, prognostically important secondary MR.
• A markedly asymmetrical or unexpectedly low-velocity CW envelope isn’t reassuring on its own — consider whether it reflects very elevated left atrial pressure rather than mild disease.
• In an apparently asymptomatic patient with at least moderate MR, exercise stress echocardiography can unmask symptoms and risk-stratify via the sPAP response — see Stress Echocardiography for the specific prognostic markers involved.